Expression of KIT (CD117) in biphasic pulmonary blastoma. Novel data on histogenesis

Lung

Volumn 181, Issue 4, 2003, Pages 193-200

  Hansen, T ^a   Bittinger, F ^a   Kortsik, C ^b   Wagner, B ^b   Kirkpatrick, C J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b St Hildegardis Krankenhaus   (Germany)

Author keywords

Biphasic pulmonary blastoma; CD117; Histogenesis; Immunohistochemistry

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ANTIBODY; CD99 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG BLASTOMA; LUNG CARCINOGENESIS; LUNG LOBE; MALE; MESENCHYME; PRIORITY JOURNAL;

HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0141840731     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-003-1021-2     Document Type: Article

References (14)

1. Berean K, Truong LD, Dudley AW, Cagle PT (1988) Immunohistochemical characterization of pulmonary blastoma. Am J Clin Pathol 89:773-777
2. Bodner SM, Koss MN (1996) Mutations in the p53 gene in pulmonary blastomas: immunohistochemical and molecular studies. Hum Pathol 27:1117-1123
3. Colby TV, Koss MN, Travis WD (1994) Mixed epithelial and mesenchymal tumors. In: Rosai J, Sobin LH (eds) Tumors of the lower respiratory tract, 3rd series, Fascicle 13. American Registry of Pathology, Washington DC, pp 295-410
4. Gibson PC, Cooper K (2002) CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 9:65-69
5. Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692-1703
6. Holst VA, Finkelstein S, Colby TV, Myers JL, Yousem SA (1997) p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol 21:801-811
7. Koss MN, Hochholzer L, O'Leary T (1991) Pulmonary blastomas. Cancer 67:2368-2381
8. Krystal GW, Honsawek S, Litz J, Buchdunger E (2000) The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. Clin Cancer Res 6:3319-3326
9. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C (1994) Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 42:1417-1425
10. Miettinen M, Limon J, Niezabitowski A, Lasota J (2000) Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch 437:275-283
11. Pacinda SJ, Ledet SC, Gondo MM, Langston C, Brown RW, Carmona PA, Franklin RB, Roggli VL, Cagle PT (1996) p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas. Hum Pathol 25:542-546
12. Pietsch T, Nicotra MR, Fraioli R, Wolf HK, Mottolese M, Natali PG (1998) Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas. Int J Cancer 75:171-175
13. Tamborini E, Papini D, Mezzelani A, Riva C, Azzarelli A, Sozzi G, Pierotti MA, Pilotti S (2001) c-KIT and c-KIT Iigand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases. Br J Cancer 85:405-411
14. Yousem S, Wick MR, Randhawa P, Manivel JC (1990) Pulmonary blastoma. An immunohistochemical analysis with comparison with fetal lung in its preglandular stage. Am J Clin Pathol 93:167-175